From Yahoo Finance: 2025-06-11 14:41:00

Biotech stock Crispr Therapeutics Inc (NASDAQ:CRSP) is seeing its June rally slow down, with shares down 0.6% at $42.69. The stock is now showing a bearish signal on the charts after hitting its highest level since March.

CRSP has moved up towards its 260-day moving average, within 0.75 of the trendline’s 20-day average true range. Historical data shows that after similar signals in the past, CRSP was lower one month later 80% of the time, averaging an 8% loss.

Options activity on CRSP has been bullish, with 14.50 calls bought for every put in the last two weeks. This high ratio indicates optimism among traders, but an unwinding of this sentiment could lead to further headwinds for the stock.

Read more: Biotech Stock for Options Bears to Target Right Now